Impact of mutations in SARS-COV-2 spike on viral infectivity and antigenicity

Brief Bioinform. 2021 Sep 13:bbab375. doi: 10.1093/bib/bbab375. Online ahead of print.ABSTRACTSince the outbreak of SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, the viral genome has acquired numerous mutations with the potential to alter the viral infectivity and antigenicity. Part of mutations in SARS-CoV-2 spike protein has conferred virus the ability to spread more quickly and escape from the immune response caused by the monoclonal neutralizing antibody or vaccination. Herein, we summarize the spatiotemporal distribution of mutations in spike protein, and present recent efforts and progress in investigating the impacts of those mutations on viral infectivity and antigenicity. As mutations continue to emerge in SARS-CoV-2, we strive to provide systematic evaluation of mutations in spike protein, which is vitally important for the subsequent improvement of vaccine and therapeutic neutralizing antibody strategies.PMID:34518867 | DOI:10.1093/bib/bbab375
Source: Briefings in Bioinformatics - Category: Bioinformatics Authors: Source Type: research